I’m joined by special guest Matt McKenzie @mgm485 as we discuss all things related to Immunotherapy.
Looking for Part I? Click here
Since early 2020 there have been quite a few changes in this world, and we discuss all of them. We review what immunotherapy is, when are we currently using this treatment, how are CAR-T products made, standard ICU work-up, common adverse effects: cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS), common treatments: tocilizumab, corticosteroids, and anakinra, grading and monitoring ADE, immune checkpoint inhibitors, most common organ system affected by ICI A, re-challenging after ADE, role of the Pharmacist in prevention/treatment, take-home points, and so much more.
Leave a comment